OREX
Orexigen Therapeutics, Inc.
OREX
OREX
Delisted
OREX was delisted on the 3rd of April, 2018.
161 hedge funds and large institutions have $564M invested in Orexigen Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 50 increasing their positions, 51 reducing their positions, and 29 closing their positions.
Holders
161
Holders Change
+1
Holders Change %
+0.63%
% of All Funds
4.34%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.11%
New
30
Increased
50
Reduced
51
Closed
29
Calls
$7.84M
Puts
$5.37M
Net Calls
+$2.47M
Net Calls Change
+$8.72M
Top Buyers
| 1 |
CS
1
Credit Suisse
Zurich,
Switzerland
|
$19.9M |
| 2 |
SC
2
Samlyn Capital
New York
|
$29.9M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$36.8M |
| 4 |
PHS
4
PFM Health Sciences
San Francisco,
California
|
$26.1M |
| 5 |
5
Millennium Management
New York
|
$23M |
